Skip to content

Member

Angelika NIEBLER

EPP · Germany

Group
EPP PPE
Country
Germany
Roll-call participation
89.4 %ⓘ of 620 roll calls in office · chamber median 90.6 % · whole term, final votes
With majority line
97.7 %ⓘ of 554 votes where the group had a line · EPP median 95.6 %
More facts (5)
National party
CSU Christlich-Soziale Union in Bayern e.V.
In office
Since 16 Jul 2024
Against clear line
12 of 521 votesⓘ
Committees
AFET (substitute), INTA, ITRE, JURI (substitute), SEDE (substitute)
Member id
4289
More

Record

The member’s figures against the median of their group and of the chamber. Each vote counts the member in the group they belonged to that day.

Roll-call participation ⓘ

89.4 %

554 of 620 final votes while in office

EPP median: 90.6 % (−1.2 pts)

Chamber median: 90.6 %

With majority line ⓘ

97.7 %

541 of 554 votes where their group had a line

EPP median: 95.6 % (+2.1 pts)

Against clear line ⓘ

2.3 %

12 of 521 votes where their group had a clear line

8 opposite (for ↔ against), 4 abstained against the line

Abstention ⓘ

0.7 %

4 of 554 votes cast

Participation 89.4 % — EPP median 90.6 %, 192 members.ⓘ
Data as a table
Participation among the 192 members of the EPP with enough votes.
FigureParticipation
Angelika NIEBLER89.4 %
EPP median90.6 %
Lowest in the group18.4 %
Highest in the group99.8 %
Members192
With majority line 97.7 % — EPP median 95.6 %, 192 members.ⓘ
Data as a table
With majority line among the 192 members of the EPP with enough votes.
FigureWith majority line
Angelika NIEBLER97.7 %
EPP median95.6 %
Lowest in the group67.8 %
Highest in the group99.0 %
Members192
  • Whole term, 620 final votes; 620 of 794 decisions had a final vote recorded by name. The dots are the other members of EPP; no ranks.
  • “No vote recorded” is not the same as absent: leave, illness and chairing the sitting look the same.
  • A group’s line is inferred from its members’ votes — Parliament publishes no whip.

Votes, 5 928

Export

Every roll-call vote of the term with the member’s position, newest first.

Result: for–against–abstained. Majority line: how most of the member’s group voted that day (“Tie” when no position won). ≠ group marks a vote otherwise than a clear line (at least two thirds, with at least 10 members voting) of their group.
DateDecision and voteResultPositionMajority line
9 Sept 2025EU-Kyrgyz Republic Enhanced Partnership and Cooperation Agreement (Resolution) Final vote — text as a wholeAdopted 434 for, 49 against, 168 abstainedPosition: For Majority line: For
9 Sept 2025EU-Kyrgyz Republic Enhanced Partnership and Cooperation Agreement (Resolution) Amendment 12, adding text after paragraph 12 72 for, 522 against, 51 abstainedPosition: Against Majority line: Against
9 Sept 2025EU-Kyrgyz Republic Enhanced Partnership and Cooperation Agreement Final vote on the draft Council decisionConsent given 473 for, 114 against, 58 abstainedPosition: For Majority line: For
9 Sept 2025EU-Brazil Agreement: cooperation with and through Europol and the Federal Police of Brazil Final vote on the draft Council decisionConsent given 606 for, 5 against, 19 abstainedPosition: For Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Final votePassed 431 for, 145 against, 76 abstainedPosition: For Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 395 to recital 19 187 for, 442 against, 16 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendments 409 + 417 (voted as one) to Annex VII, Part C, point 16 208 for, 431 against, 7 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 371 to Annex VII, Part C, point 13 530 for, 112 against, 4 abstainedPosition: For Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendments 408 + 416 (voted as one) to Annex VII, Part C, point 6 204 for, 438 against, 8 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 407 to Annex VII, Part C, point 4 137 for, 447 against, 61 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 318 to Article 55, après le paragraph 2 512 for, 120 against, 14 abstainedPosition: For Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 390 to Article 55, après le paragraph 2 105 for, 538 against, 3 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 389 to Article 38, paragraph 3, après le point b 96 for, 549 against, 3 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 388 to Article 18, paragraph 1 124 for, 515 against, 7 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 387 to Article 7, après le paragraph 4 207 for, 431 against, 10 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 137 to Article 6, paragraph 3, alinéa 1 — part 2 451 for, 182 against, 10 abstainedPosition: For Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 137 to Article 6, paragraph 3, alinéa 1 — part 1 461 for, 185 against, 5 abstainedPosition: For Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 394 to Article 6, paragraph 1, après l'alinéa 2 142 for, 496 against, 8 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 403 to Article 6, paragraph 1, alinéa 2 192 for, 442 against, 11 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 130 to Article 6, paragraph 1, alinéa 1 444 for, 189 against, 14 abstainedPosition: For Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 402 to Article 6, paragraph 1, alinéa 1 194 for, 434 against, 15 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 393 to Article 6, paragraph 1, alinéa 1 120 for, 529 against, 2 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 150 to Article 6 — part 2 438 for, 196 against, 8 abstainedPosition: For Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 150 to Article 6 — part 1 452 for, 195 against, 2 abstainedPosition: For Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 134 to Article 6 473 for, 154 against, 22 abstainedPosition: For Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 133 to Article 6 — part 2 512 for, 122 against, 15 abstainedPosition: For Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 133 to Article 6 — part 1 505 for, 126 against, 19 abstainedPosition: For Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 401 to Article 6 131 for, 447 against, 72 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 392 to Article 4, après le paragraph 1 138 for, 504 against, 4 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 391 to Article 4, paragraph 1, après le point b 138 for, 508 against, 2 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendments 399 + 412 (voted as one) to Article 3, paragraph 1, point 15 168 for, 445 against, 36 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 398 to Article 3, paragraph 1, après le point 9 199 for, 437 against, 11 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 397 to Article 3, paragraph 1, point 9 158 for, 471 against, 17 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 396 to Article 2, paragraph 6, partie introductive 197 for, 418 against, 30 abstainedPosition: Against Majority line: Against
8 Sept 2025Wednesday’s agenda – Request by the PPE Group Ordre du jour de mercredi — Demande du groupe PPE 384 for, 10 against, 51 abstainedPosition: For Majority line: For
10 Jul 2025Tackling China’s critical raw materials export restrictions Final vote — text as a wholeAdopted 523 for, 75 against, 14 abstainedPosition: For Majority line: For
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 1 to paragraph 14 157 for, 428 against, 36 abstainedPosition: Against Majority line: Against
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 8, adding text after paragraph 13 95 for, 420 against, 119 abstainedPosition: Against Majority line: Against
10 Jul 2025Tackling China’s critical raw materials export restrictions Paragraph 13 — part 2 483 for, 84 against, 67 abstainedPosition: For Majority line: For
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 7 to paragraph 13 80 for, 407 against, 151 abstainedPosition: Against Majority line: Against
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 6, adding text after paragraph 12 79 for, 531 against, 18 abstainedPosition: Against Majority line: Against
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 5 to paragraph 10 47 for, 560 against, 27 abstainedPosition: Against Majority line: Against
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 4 to paragraph 8 88 for, 520 against, 22 abstainedPosition: Against Majority line: Against
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 3, adding text after paragraph 2 63 for, 552 against, 15 abstainedPosition: Against Majority line: Against
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 2, adding text after paragraph 1 123 for, 390 against, 110 abstainedPosition: Against Majority line: Against
10 Jul 2025Future of the EU biotechnology and biomanufacturing sector: leveraging research, boosting innovation and enhancing competitiveness Final vote — text as a wholeAdopted 494 for, 83 against, 71 abstainedPosition: For Majority line: For
10 Jul 2025Future of the EU biotechnology and biomanufacturing sector: leveraging research, boosting innovation and enhancing competitiveness Amendment 2, adding text after recital S 217 for, 409 against, 23 abstainedPosition: Against Majority line: Against
10 Jul 2025Future of the EU biotechnology and biomanufacturing sector: leveraging research, boosting innovation and enhancing competitiveness Amendment 1, adding text after citation 2 226 for, 409 against, 17 abstainedPosition: Against Majority line: Against
10 Jul 2025Future of the EU biotechnology and biomanufacturing sector: leveraging research, boosting innovation and enhancing competitiveness Paragraph 34 — part 2 566 for, 60 against, 23 abstainedPosition: For Majority line: For
10 Jul 2025Future of the EU biotechnology and biomanufacturing sector: leveraging research, boosting innovation and enhancing competitiveness Paragraph 32 — part 1 588 for, 56 against, 7 abstainedPosition: For Majority line: For

Show all 50 votes on this page

Roll-call participation

One cell per sitting while in office, shaded by the share of that day’s roll calls the member voted in. The official attendance register is kept separately by Parliament.

No vote recorded on 8 of 80 sittings with roll calls.

"No vote recorded" is not the same as absent: leave, illness and chairing the sitting look the same.

Data as a table

Voting neighbours

Members who voted the same way most often in the roll calls they both took part in, within and outside the member’s group (group at the date of each vote), over all roll calls of the term.

At least 200 shared roll calls over at least six months in office together. Within = both sat in the same group on the date of the vote; a member who changed group can appear on both lists. Baseline = the median agreement of all pairs of members of the groups the two sat in on the date of each shared vote (within: the group they shared; outside: the two groups), weighted by the votes they shared in each combination.

Within EPP

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in the same group (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of that group.
SelectMemberGroupCountryAgreementBaseline
Stefan KÖHLER EPPGermany99 % of 4 711 shared89 %
Manfred WEBER EPPGermany99 % of 4 187 shared89 %
Axel VOSS EPPGermany99 % of 4 263 shared89 %
Alexandra MEHNERT EPPGermany99 % of 4 638 shared89 %
Verena MERTENS EPPGermany99 % of 4 624 shared89 %
Christine SCHNEIDER Former memberEPPGermany99 % of 3 024 shared89 %
Oliver SCHENK EPPGermany98 % of 5 122 shared89 %
Ralf SEEKATZ EPPGermany98 % of 4 617 shared89 %
Lena DÜPONT EPPGermany98 % of 4 170 shared89 %
Marion WALSMANN EPPGermany98 % of 5 062 shared89 %

Show all 10 neighbours

Outside the group

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in different groups (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of the groups the two sat in on those votes (groups at the date, weighted by the votes shared in each combination).
SelectMemberGroupCountryAgreementBaseline
Urmas PAET RenewEstonia90 % of 4 622 shared82 %
Dan BARNA RenewRomania88 % of 4 529 shared82 %
Hilde VAUTMANS RenewBelgium88 % of 5 016 shared82 %
Jan-Christoph OETJEN RenewGermany87 % of 5 025 shared82 %
Katri KULMUNI RenewFinland87 % of 4 220 shared82 %
Moritz KÖRNER RenewGermany87 % of 5 078 shared82 %
Bart GROOTHUIS RenewNetherlands87 % of 4 076 shared82 %
Andreas GLÜCK RenewGermany87 % of 3 752 shared82 %
Elsi KATAINEN RenewFinland87 % of 5 077 shared82 %
Olivier CHASTEL RenewBelgium87 % of 4 655 shared82 %

Show all 10 neighbours

Work

Seats in committees, delegations and intergroups, and the dossiers the member leads, shadows or negotiates.

Seats

Body: the committee, delegation or intergroup, with its kind. Role: the member’s role in it. From, To: the dates of the seat (“now” while it lasts).
BodyRoleFromTo
Committee on Foreign AffairsAFET CommitteeSubstitute19 Jul 2024now
Committee on International TradeINTA CommitteeMember25 Mar 2026now
Committee on Industry, Research and EnergyITRE CommitteeMember19 Jul 2024now
Committee on Legal AffairsJURI CommitteeSubstitute19 Jul 2024now
Committee on Security and DefenceSEDE CommitteeSubstitute23 Jan 2025now
Delegation for relations with IndiaD-IN DelegationChair30 Sept 2024now
Delegation for relations with the United StatesD-US DelegationSubstitute19 Sept 2024now
Delegation for relations with the countries of Southeast Asia and the Association of Southeast Asian Nations (ASEAN)DASE DelegationMember19 Sept 2024now
Intergroup on Children’s RightsIG10-06 Intergroup / working groupMember19 Feb 2025now
Intergroup on Sky and SpaceIG10-21 Intergroup / working groupVice-chair27 Feb 2025now

Show all 12 seats

Dossiers

Dossier: the procedure the declaration names (“No dossier named” for a delegation without one). Role: rapporteur, shadow rapporteur, negotiator or delegation. Committee: the committee that appointed them. Date: of the declaration.
DossierRoleCommitteeDate
No dossier namedOfficial delegationINTA29 Sept 2026
No dossier namedOfficial delegationITRE21 May 2026
No dossier namedOfficial delegationITRE22 Dec 2025
No dossier namedOfficial delegationITRE4 Dec 2025
Participation of Prof. Dr. Angelika Niebler in the INTA mission to India (27. - 29. October 2025) in the position of Chair of the Delegation for relations to IndiaOfficial delegationD-IN8 Oct 2025
Safety, resilience and sustainability of space activities in the UnionShadow rapporteurITRE23 Sept 2025
No dossier namedOfficial delegationJURI12 Sept 2025
No dossier namedOfficial delegationITRE2 Apr 2025
No dossier namedDelegation chairD-IN30 Sept 2024

Show all 9 dossier roles

Topics they work on (model-assigned)

Counts: dossiers they spoke on, led or amended, and their questions and motions.

In the chamber

Speeches and statements in plenary debates, newest first; the verbatim report is on Parliament’s site.

29 contributions recorded; 2 on behalf of their group; 47 minutes of speaking time.

Show all 29 recent contributions

Questions and motions, 18

Parliamentary questions and motions for resolutions the member authored or co-signed, newest first.

Date: tabled. Title: the question or motion, with its id. Kind: written question or motion for a resolution, with the number of co-authors. Answer: the date of the answer to a question.
DateTitleKindAnswer
16 Sept 2026Refusal of third countries to provide geolocation data and its implications for the implementation of the EU Deforestation Regulation E-10-2026-003695Written questionNot yet answered
10 Sept 2026Potential market disruption linked to the European Positive List process under Directive (EU) 2020/2184 E-10-2026-003614Written questionwith 9 co-authorsNot yet answered
23 Jul 2026Energy Performance of Buildings Directive E-10-2026-003113Written questionwith 17 co-authorsNot yet answered
15 Jul 2026Treatment of stock held by packaging wholesalers as of the PPWR application date on 12 August 2026 P-10-2026-002934Priority written question21 Aug 2026
2 Jul 2026EU financing instruments for the deployment of fusion energy infrastructure E-10-2026-002744Written questionwith 13 co-authors18 Sept 2026
15 Jun 2026MOTION FOR A RESOLUTION on Russia’s unacceptable provocative actions and drone incursions into Romania, the Baltic states and Finland B-10-2026-0304Motion for a resolutionwith 32 co-authors—
9 Jun 2026Planned ban on PFAS chemicals and impact on the food processing industry E-10-2026-002369Written questionwith 3 co-authors31 Jul 2026
6 May 2026Practical feasibility of labelling requirements for secondary and tertiary reusable packaging under Articles 12 and 15(8) PPWR E-10-2026-001856Written questionwith 12 co-authors10 Jul 2026
10 Feb 2026MOTION FOR A RESOLUTION on four years of Russia’s war of aggression against Ukraine and European contributions to a just peace and sustained security for Ukraine B-10-2026-0146Motion for a resolutionwith 29 co-authors—
20 Nov 2025EU customs policy and unequal treatment vis-à-vis Asian low-cost suppliers P-10-2025-004641Priority written question21 Jan 2026

Show all 18 questions and motions

Amendments tabled in committee, 115

Committee amendment documents that carry amendments by the member, with how many are theirs.

Date: of the amendment document. Text amended: the dossier and the document’s id. Committee: where the amendments were tabled. Amendments: how many in the document are the member’s.
DateText amendedCommitteeAmendments
17 Sept 2026Mobile satellite services: selection and authorisation of systems using the harmonised 2 GHz frequency band ITRE-AM-792052 ITRE36
17 Sept 2026Mobile satellite services: selection and authorisation of systems using the harmonised 2 GHz frequency band ITRE-AM-792193 ITRE34
10 Sept 2026on the proposal for a Regulations (EC) No 561/2006, (EU) 2018/858, (EU) 2019/2144 and (EU) 2024/1257 of the European Parliament and of the Council as regards the simplification of technical requirements and testing procedures for motor vehicles and repealing Council Directive 70/157/EEC and Regulation No 540/2014 of the European Parliament and of the Council ITRE-AM-790812 ITRE39
28 Jul 2026Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex I SANT-AM-791890 SANT1
28 Jul 2026Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex I SANT-AM-791891 SANT2
28 Jul 2026Amending Directives 2008/98/EC, 2010/75/EU, (EU) 2015/2193 and (EU) 2024/1785 of the European Parliament and of the Council as regards simplification of some requirements and reduction of administrative burden ENVI-AM-791123 ENVI15
28 Jul 2026Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex I SANT-AM-791887 SANT7
27 Jul 2026Amending Regulations (EU) 2016/679, (EU) 2018/1724, (EU) 2018/1725, (EU) 2023/2854 and Directives 2002/58/EC, (EU) 2022/2555 and (EU) 2022/2557 as regards the simplification of the digital legislative framework, and repealing Regulations (EU) 2018/1807, (EU) 2019/1150, (EU) 2022/868, and Directive (EU) 2019/1024 (Digital Omnibus) CJ72-AM-791073 CJ7215
27 Jul 2026Amending Regulations (EU) 2016/679, (EU) 2018/1724, (EU) 2018/1725, (EU) 2023/2854 and Directives 2002/58/EC, (EU) 2022/2555 and (EU) 2022/2557 as regards the simplification of the digital legislative framework, and repealing Regulations (EU) 2018/1807, (EU) 2019/1150, (EU) 2022/868, and Directive (EU) 2019/1024 (Digital Omnibus) CJ72-AM-791874 CJ7210
27 Jul 2026Amending Regulations (EU) 2016/679, (EU) 2018/1724, (EU) 2018/1725, (EU) 2023/2854 and Directives 2002/58/EC, (EU) 2022/2555 and (EU) 2022/2557 as regards the simplification of the digital legislative framework, and repealing Regulations (EU) 2018/1807, (EU) 2019/1150, (EU) 2022/868, and Directive (EU) 2019/1024 (Digital Omnibus) CJ72-AM-790967 CJ723

Show all 115 amendment documents

Connections

Dossiers they lead or shadow, committees, party, delegation and other related pages.

Political group

National delegation

  • Delegation Germany National delegation

Sources & citation

Where the facts on this page come from, and how to cite it.

Data source
Licensed CC BY 4.0.
Data version
data version 7669c786bb14 (1 Oct 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1 · methods
Retrieved
1 October 2026

Cite as

EU Parl Watch Research (2026). “Angelika NIEBLER”. Member record. memberId 4289. EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/members/4289?page=77&scope=final&vscope=all (retrieved 1 October 2026). Official source: Member’s profile, European Parliament, https://www.europarl.europa.eu/meps/en/4289. Data: EP Open Data: member record, https://data.europarl.europa.eu/api/v2/meps/4289?format=application%2Fld%2Bjson (CC BY 4.0); data version 7669c786bb14 (1 Oct 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1.
BibTeX
@misc{epw-member-4289,
  author = {{EU Parl Watch Research}},
  title = {{Angelika NIEBLER}},
  year = {2026},
  howpublished = {\url{https://news.eu-parl.st-solutions.dev/members/4289?page=77&scope=final&vscope=all}},
  url = {https://news.eu-parl.st-solutions.dev/members/4289?page=77&scope=final&vscope=all},
  urldate = {2026-10-01},
  publisher = {EU Parl Watch Research},
  note = {Member record. memberId 4289. Official source: https://www.europarl.europa.eu/meps/en/4289. Data: EP Open Data: member record (CC BY 4.0); data version 7669c786bb14 (1 Oct 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1}
}